跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLIOTENZIDE 20 TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
GLIOTENZIDE 20 TABLET
Approved
THERAPEUTIC
GLIOTENZIDE 20 TABLET
LABORATORIOS BAGO SA (ARGENTINA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 14, 2005
Approval ID
87860eb352e26da5
Company
LABORATORIOS BAGO SA (ARGENTINA)
Type
Therapeutic
Approval Details
Approval Id
87860eb352e26da5
Drug Name
GLIOTENZIDE 20 TABLET
Product Name
GLIOTENZIDE 20 TABLET
Approval Number
SIN12641P
Approval Date
2005-01-14
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09BA02
Atc Item Name
enalapril and diuretics
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
ENALAPRIL MALEATE USP
20 mg
HYDROCHLOROTHIAZIDE USP
12.5 mg
ENALAPRIL MALEATE USP
20 MG
HYDROCHLOROTHIAZIDE USP
12.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 14, 2005
Approval ID
87860eb352e26da5
Type
Therapeutic
Back to HSA Approvals